“””Sales of our common stock, if any, under this prospectus supplement and the accompanying prospectus may be made by any method deemed to be an “at the market offering”””
Read it ,
Apparently someone didn’t approve of my previous & deleted it , lots of opposition shorts here , Geron s Imetelstat has the Mayo Clinic pilot study a couple years back that must have blew the to off & pulled in Janssen , J&J has been the applicant on Imetelstat patent applications so in my view they are locked in here. In fact Geron s name isn’t on the patent application being pub in Aug 2018 filed a couple years ago , around the same time of the ? Yes Mayo Clinic pilot study that had the kind of results that captured the attn of many in the medical , enough to fund these studies , read Imetelstatchat JMHO
News 
Market Data 
Discover 
